It’s no secret that slow enrollment is one of the major factors that leads to delays in the completion of clinical trials. And while enrollment is already challenging, the increase in clinical trial complexity, number of study procedures, and increasingly narrow trial eligibility criteria all point to the problem getting worse instead of better in the coming years!
In this webinar, the speakers will discuss through case examples ways to accelerate enrollment across the continuum of protocol development to activation by:
- Discussing pitfalls in protocol optimization
- Accurately assessing site recruitment potential
- Engaging study staff and investigators in the science behind the trial
- Encouraging implementation of effective prescreening strategies
- Implementing effective patient recruitment strategies
By attending this webinar, you will have the opportunity to learn the crucial techniques to ensure the success of your study!
Martin Lee, M.D., Vice President, Investigator Relations, PRAGretchen Goller, MSW, Sr. Director, Patient Access and Retention Services, PRA
Martin Lee, M.D., Vice President, Investigator Relations, PRA
Martin Lee received his medical degree from the University of Texas Medical School at Houston and is board certified in medical oncology. Dr. Lee has 19 years of clinical experience in the front-line care of hematology and oncology patients and has also served as an Institutional Review Board chairman and leader of a clinical research program in academic and community settings. Dr. Lee’s interests include the study of oncology drug development, clinical trial feasibility and optimizing patient recruitment to clinical trials. Dr. Lee oversees PRA’s feasibility and site identification groups and is launching an innovative clinical trial liaison program that is modeled after the success of medical science liaison programs in the Pharmaceutical industry.
Gretchen Goller, MSW, Sr. Director, Patient Access and Retention Services, PRA
Gretchen has amassed over 15 years of clinical research experience, including the start of her career as a study coordinator and then as a Site Director at the University of Pennsylvania in various therapeutic areas including ophthalmology, women’s health, HIV/AIDS, cardiology and endocrinology. Most recently Gretchen was the Patient Recruitment and Retention Strategist at Sanofi-Aventis, where her focus was all U.S. Phase II-IV clinical studies. Prior to this, she served as a contract Clinical Trial Manager at Wyeth in the Global Medical Affairs vaccines group and Astra Zeneca as a study manager in cardiology.
Gretchen is located in Jeffersonville, PA, and has a BA from the University of Massachusetts and an MSW from the University of Pennsylvania.Message Presenter
Who Should Attend?
Executives and managers in pharma and biotech in:
- Strategic Drug Development
- Clinical Operations
- Outsourcing and Procurement
- Clinical Trial Planning and Optimization
- Patient Recruitment
As the world’s fourth largest CRO, PRA is transforming clinical trials through our people, innovation and transparency. We combine therapeutic and operational expertise with local knowledge to serve clients across all phases of drug development. Our successful history of helping to bring new drugs to market demonstrates our successful approach to clinical research.
We operate in 80+ countries with more than 10,000 employees, seamlessly delivering comprehensive Embedded and clinical trial services with our advanced technological tools and finely tuned systems. Our dynamic services, operational transparency and forward-thinking approach are making a difference to healthcare patients worldwide.